ANV News Alert Allied Nevada Gold Corp (ANV) 2.04 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 9:35 PM

Allied Nevada Gold Corp (ANV) 2.04 $ANV

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 4:39PM CST

JACK: 71.50 (+1.21), LZB: 22.58 (-0.16), ANV: 2.04 (+0.37), DL: 14.97 (+0.44), ENPH: 11.09 (+0.49), VIPS: 23.71 (-0.28), NLNK: 32.66 (+1.75), WLT: 2.93 (-0.09), ODP: 6.69 (unch), JDST: 14.66 (-3.93)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:49AM CST

BOSC: 3.83 (-0.30), ANV: 2.04 (+0.37), BONE: 3.16 (-0.37), TERP: 32.75 (+6.91), BDR: 2.20 (+0.54), AMRN: 1.32 (+0.25), NBS: 4.78 (-2.00), YOKU: 19.60 (-2.37), AMCF: 1.52 (+0.19), GSAT: 2.55 (-0.25), MUX: 1.64 (+0.24), URBN: 28.79 (-2.04), CANF: 3.00 (+0.57), TRT: 3.10 (-0.42), CBSO: 26.93 (-3.71), OME: 12.45 (-2.53), ATLC: 2.31 (+0.41), SUNE: 21.48 (+4.87), FWM: 2.80 (+0.57)

SunEdison Flies Sky-High On Acquisition Deal
at The Street - Tue Nov 18, 11:37AM CST
Sunedison Inc (NYSE:SUNE), Allied Nevada Gold Corp. (NYSEMKT:ANV) and InvenSense Inc (NYSE:INVN) hit midday in the green this Tuesday. Globalstar, Inc. (NYSEMKT:GSAT), Cal Dive International, Inc. (O...
ANV: 2.04 (+0.37), SUNE: 21.48 (+4.87), INVN: 15.00 (+0.96), GSAT: 2.55 (-0.25)

Allied Nevada Gold (ANV) Stock Rises as Gold Prices Rally
at The Street - Tue Nov 18, 9:06AM CST
Shares of Allied Nevada Gold (ANV) surged in morning trading Tuesday as gold prices rallied.
ANV: 2.04 (+0.37)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 8:13AM CST

ANV: 2.04 (+0.37), AMCN: 2.47 (+0.12), UEC: 1.90 (unch), OME: 12.45 (-2.53), JASO: 8.49 (+0.69), ONVO: 6.74 (+0.60), SUNE: 21.48 (+4.87), NBS: 4.78 (-2.00), CYTR: 2.52 (-0.24), SNSS: 2.07 (-0.24), ETE: 64.48 (+1.77), GSAT: 2.55 (-0.25)

Traders Get Bullish on Shares of Allied Nevada Gold, Shares Up 15.0% (ANV)
Comtex SmarTrend(R) - Mon Nov 17, 2:43PM CST
Allied Nevada Gold (AMEX:ANV) is one of today's best performing low-priced stocks, up 15.0% to $1.58 on 1.0x average daily volume. Thus far today, Allied Nevada Gold has traded 4.8 million shares, vs. average volume of 4.7 million shares per day. The stock has outperformed the Dow (15.0% to the Dow's 0.0%) and outperformed the S&P 500 (15.0% to the S&P's -0.0%) during today's trading.
ANV: 2.04 (+0.37)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:18AM CST

ANV: 2.04 (+0.37), KEP: 20.20 (-0.14), RADA: 2.54 (+0.24), SEAS: 17.06 (+0.12), HPJ: 6.09 (+0.02), PLUG: 4.04 (+0.32), SUPN: 9.07 (+0.81), NBG: 2.25 (+0.07), GV: 2.06 (+0.03), OXGN: 1.78 (-0.05), NOAH: 17.05 (+0.52), FOSL: 108.02 (+0.60), AEO: 13.26 (-0.08), IBIO: 1.09 (+0.03), MTOR: 13.78 (-0.20), MLNX: 43.00 (+0.51), SUSQ: 13.10 (+0.06)

Strong On High Volume: Allied Nevada Gold (ANV)
at The Street - Mon Nov 10, 9:03AM CST
Trade-Ideas LLC identified Allied Nevada Gold (ANV) as a strong on high relative volume candidate
ANV: 2.04 (+0.37)

Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 2.04 (+0.37), AMSC: 1.05 (+0.06), RPRX: 9.19 (-0.14), SHLD: 35.91 (+0.29), STAY: 18.52 (-0.04)

Allied Nevada Files NI 43-101 Technical Report for Hycroft Mill Expansion Feasibility Study
Marketwired - Fri Nov 07, 2:10PM CST
Allied Nevada Gold Corp. ("Allied Nevada", "us", "we", "our" or the "Company"

(TSX: ANV)(NYSE MKT: ANV) announces the filing on SEDAR of a National Instrument ("NI"

43-101 Technical Report representing the qualifying report for the recently announced feasibility study for the Hycroft mill expansion project (see Allied Nevada press release dated October 15, 2014).
ANV: 2.04 (+0.37), ANV.TO: 2.30 (+0.38)

Hot Stock: Allied Nevada Gold, Shares Gain 18.5% (ANV)
Comtex SmarTrend(R) - Fri Nov 07, 11:38AM CST
Allied Nevada Gold (AMEX:ANV) is one of today's best performing low-priced stocks, up 18.5% to $1.02 on 1.0x average daily volume. Allied Nevada Gold has traded 4.0 million shares thus far today, vs. average volume of 3.9 million shares per day. The stock has outperformed the Dow (18.5% to the Dow's 0.1%) and outperformed the S&P 500 (18.5% to the S&P's 0.1%) during today's trading.
ANV: 2.04 (+0.37)

Technical Summary on Gold Equities - Allied Nevada Gold, AngloGold Ashanti, AuRico Gold, Harmony Gold Mining, and Sandstorm Gold
PR Newswire - Fri Nov 07, 8:20AM CST
Investor-Edge has initiated coverage on the following equities: Allied Nevada Gold Corporation (NYSE MKT: ANV), AngloGold Ashanti Ltd (NYSE: AU), AuRico Gold Inc. (NYSE: AUQ), Harmony Gold Mining Company Ltd (NYSE: HMY), and Sandstorm Gold Ltd (NYSE MKT: SAND). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 06, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,554.47, up 0.40% and the NASDAQ Composite closed at 4,638.47, up 0.38%. The S&P 500 finished the session 0.38% higher at 2,031.21. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 304.24, up 0.82%, with the index advancing 4.32% on YTD basis. Register for your complimentary reports on these five stocks at:
ANV: 2.04 (+0.37), HMY: 1.87 (+0.12), AUQ: 4.15 (+0.20), SAND: 3.26 (+0.15), AU: 10.27 (+0.61)

Allied Nevada Has Been Left For Dead: Why A Speculative Long Position Makes Sense
Ben Kramer-Miller - Seeking Alpha - Thu Nov 06, 9:19AM CST
About a year ago, I wrote an article in which I suggested that Allied Nevada (NYSEMKT: ANV ) was a poor investment. In spite of the fact that its Hycroft Mine is a high-quality asset, this quality was mitigated by the company's debt load. While the...
ANV: 2.04 (+0.37)

Update: Allied Nevada's Earnings
Ben Kramer-Miller - at Seeking Alpha - Wed Nov 05, 10:03AM CST

ANV: 2.04 (+0.37)

Update: Allied-Nevada Gold Earnings
The Investment Doctor - at Seeking Alpha - Wed Nov 05, 6:15AM CST

ANV: 2.04 (+0.37)

Allied Nevada Gold's (ANV) CEO Randy Buffington on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:10PM CST

ANV: 2.04 (+0.37)

Update: Allied Nevada Earnings Show The Company Is In Serious Trouble
Hard Asset Investments - at Seeking Alpha - Tue Nov 04, 3:24PM CST

ANV: 2.04 (+0.37)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...